secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCURAY INC (ARAY)
CIK:        0001138723
Form:       8-K
Filed at:   2026-07-29T21:25:17+00:00
Accession:  0001437749-26-024904
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accuray restructures with TCW: $40M debt to preferred, $15M cash, covenant holiday through 2027
--------------------------------------------------------------------------------

- TCW exchanges $40M term loan for convertible preferred stock at $0.50/share (105.4% premium to prior close), 8% dividend.
- TCW invests $15M cash for additional preferred shares; $5M delayed draw term loan made available.
- Financial covenant holiday through Dec 31, 2027; first test date Mar 31, 2028.
- Board reduced to 7; TCW appoints 2 directors (Steven Mayer, Chan Galbato); Beverly Huss and Anne LeGrand resigned.
- Non-binding LOIs with Samsung HME America (imaging) and RaySearch Laboratories (adaptive therapy) to accelerate innovation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138723/000143774926024904/0001437749-26-024904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138723/000143774926024904/aray20260729_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-024904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer